Omni BIO Pharmaceutical, INC.
SEC CIK 1389870 · ombp · last insider filing 2015-04-09
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Schneider Bruce E. | Director · Chief Executive Officer | filed 2013 - 2015 |
| Bathgate Steven Mark | Director | filed 2009 - 2013 |
| Barone Vicki D E | Director · Chairperson of the Board | filed 2009 - 2013 |
| Wrobel Sandra J | Director | filed 2013 - 2013 |
| Kamarck Michael E. | Director | filed 2013 - 2013 |
| Iseman Michael D. | Director | filed 2009 - 2012 |
| Crapo James D | Director · CEO | filed 2011 - 2011 |
| Dinarello Charles A | Director · Acting Chief Executive Officer | filed 2009 - 2009 |
| Sperber Jeffrey S | Director | filed 2009 - 2009 |
| Sarmat, LLC | Director · President | filed 2007 - 2009 |
| Dragul Paul H | Director | filed 2009 - 2009 |
| Wort Michael D. | Director | filed 2009 - 2009 |
| Kramer Albert L | Director | filed 2009 - 2009 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Riccardi John F | Chief Financial Officer | filed 2014 - 2014 |
| Ogden Robert Cecil | Chief Financial Officer | filed 2009 - 2013 |
| Larkin Edward C. | Interim CFO | filed 2009 - 2011 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.